InvestorsHub Logo

TheFinalCD

10/25/17 8:42 AM

#2 RE: Avispa #1

Cellect Announces a Major Breakthrough of its ApoGraft™ Technology: Reporting Today Positive Results from a 20 Patients Trial With Tel-Aviv Ichilov Medical Center
https://finance.yahoo.com/news/cellect-announces-major-breakthrough-apograft-110000187.html

http://cellect.co/investors--cellect-nasdaq-listing-and-stock-quote.html

https://finviz.com/quote.ashx?t=APOP



9.90